Navigation Links
Impotence Drugs May Aid Brain Tumor Treatment
Date:5/12/2010

Levitra, Viagra allowed anti-cancer medication to more easily penetrate brain barrier, study found

WEDNESDAY, May 12 (HealthDay News) -- A drug already approved for the treatment of erectile dysfunction may actually help boost the effectiveness of treatments for brain tumors tied to both lung and breast cancer, research shows.

The finding stems from an animal study that indicated that leading erectile dysfunction medications sildenafil (Viagra) and vardenafil (Levitra) can enable the chemotherapy drug Herceptin to more easily penetrate the so-called blood-brain barrier that must be breached in order to successfully target cancer that has spread to the brain.

Although the blood-brain barrier is a naturally occurring mechanism designed to protect the brain from exposure to dangerous substances, in the case of cancer treatment it can significantly impede drug delivery, particularly of large-molecule drugs, such as Herceptin. However, erectile dysfunction drugs appear to increase the barrier's permeability.

"No matter how effective against cancer a chemotherapeutic agent may be, it can have little impact on brain tumors if it cannot cross the blood-brain tumor barrier," Dr. Keith Black, chairman of Cedars-Sinai's department of neurosurgery and director of the Maxine Dunitz Neurosurgical Institute in Los Angeles, said in a news release. "As we find new drugs that are able to target these tumor cells, it is imperative that we develop better ways to enable the medications to reach their targets."

The study team notes that about 220,000 Americans develop brain tumors each year as a result of cancers that begin elsewhere in the body. Lung cancer, they note, is the leading cause of cancer mortality in the United States, and about one-fifth of lung cancer cases end up spreading to the brain.

Work with mice demonstrated that initial Levitra exposure effectively doubled the amount of Herceptin that was able to reach brain tumors linked to lung and breast cancer.

What's more, when administering Herceptin and Levitra together, survival among the mice increased by 20 percent compared to treatment with just Herceptin alone.

The findings were published online recently in the journal PLoS One.

More Information

For more on brain tumors, visit the U.S. National Cancer Institute.



-- Alan Mozes



SOURCE: Cedars-Sinai Medical Center, news release, May 7, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Monitoring and control can limit side effects of promising cancer drugs
2. Parkinsons Drugs Tied to Compulsive Behaviors
3. Stomach Acid Drugs Come with Dangers, Studies Show
4. Anemia Drugs Hold Dangers for Kidney Patients
5. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
6. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
7. OTC Drugs May Work Differently in Obese Kids
8. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
9. BATTLE links potential biomarkers to drugs for lung cancer
10. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
11. Cholesterol Drugs May Slow MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
(Date:7/20/2017)... ... 2017 , ... For individuals with extended hospital stays or who are residents ... facilities are specially designed to accommodate patients with a wide range of ailments or ... Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... Team Type ... access to medicine for everyone affected by diabetes, is teaming up with a Microsoft ... global event kicks off on July 24th. , “Team Type 1’s mission overlaps ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... July 10, 2017  The tenth annual BioPharm ... MA at the Sheraton Boston Hotel, September ... access to global decision makers and innovative biotech startup ... science leaders during two impactful days. BioPharm America is ... with additional networking opportunities with 4,500+ life science industry ...
(Date:7/5/2017)... of over 2,000 employees and a leader in environmental and life science testing, ... position as the top American owned and operated environmental testing firm in ... ... The ... , enhances Pace Analytical,s capability as an innovative full service provider in the ...
(Date:6/30/2017)... POINT, N.C. , June 29, 2017  Axium Pharmaceuticals Inc. ... for developing improved novel formulations and alternative dosage forms of ... ... delivery is based on our waterless self-nano emulsifying formula, which ... contact with saliva. We believe the spray will provide fast ...
Breaking Medicine Technology: